Cite

HARVARD Citation

    Herrath, J. et al. (n.d.). CTLA-4-IG (ABATACEPT) therapy reduces t cell function for all defined cd4 cell subsets including regulatory T cells (TREG). Annals of the rheumatic diseases. p. A4. [Online]. 
  
Back to record